Rudolf Widmann

Director/Board Member at SHIELD THERAPEUTICS PLC

Health Technology

Consumer Services

Profile

Rudolf S.
Widmann is the founder of AOP Orphan Pharmaceuticals GmbH, founded in 1996, where the title held is Chief Therapeutics Development Officer & Director.
The current job is Non-Executive Director at Shield Therapeutics Plc starting in 2024.
Former jobs include Principal at Max Planck Institute of Neurobiology, Head-Medical Services at Wellcome Austria Pharma GmbH, and Senior Medical Marketing Adviser at Glaxo Wellcome Pharma GmbH.

Rudolf Widmann active positions

Companies	Position	Start
SHIELD THERAPEUTICS PLC	Director/Board Member	2024-07-02
Aop Orphan Pharmaceuticals GmbH Aop Orphan Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical specialties	Founder	1995-12-31

All active positions of Rudolf Widmann

Former positions of Rudolf Widmann

Companies	Position	End
Wellcome Austria Pharma GmbH	Corporate Officer/Principal	-
Glaxo Wellcome Pharma GmbH	Corporate Officer/Principal	-
Max Planck Institute of Neurobiology Max Planck Institute of Neurobiology Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-

See the detail of Rudolf Widmann's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Rudolf Widmann's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
Aop Orphan Pharmaceuticals GmbH Aop Orphan Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical specialties	Health Technology
Max Planck Institute of Neurobiology Max Planck Institute of Neurobiology Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Wellcome Austria Pharma GmbH
Glaxo Wellcome Pharma GmbH
Shield Therapeutics Plc Shield Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops and commercializes late stage pharmaceutical products	Health Technology